Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Shanghai RAAS Blood Products Co., Ltd. (002252.SZ), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
27.44
P/B ratioShare price divided by book value per share.
1.01
P/S ratioMarket value divided by annual revenue.
4.93
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
24.19
EV / RevenueEnterprise value against annual revenue.
5.21
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
3.64%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
35.41%
Operating marginRevenue left after operating costs.
14.50%
Net marginRevenue left after every cost, including tax and interest.
18.29%
Return on equityProfit as a percentage of shareholders’ equity.
3.73%
Return on assetsProfit as a percentage of total assets.
1.94%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
4.49
Quick ratioThe same, excluding inventory.
2.08
Debt to equityTotal borrowings against shareholders’ equity.
0.11
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.18
Book value per shareShareholders’ equity divided by shares outstanding.
$4.88
Shares outstandingShares currently issued.
6,592,672,885
Market capitalisationShare price times shares outstanding.
$32.57B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
4,045
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
1.61%
Payout ratioShare of profit paid out as dividends.
What is Shanghai RAAS Blood Products Co., Ltd.'s P/E ratio?
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) trades on a price-to-earnings ratio of 27.44.
What is Shanghai RAAS Blood Products Co., Ltd.'s return on equity?
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) reports a return on equity of 3.73%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Shanghai RAAS Blood Products Co., Ltd. carry?
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) has a debt-to-equity ratio of 0.11, which compares total borrowings with shareholders' equity.
What is Shanghai RAAS Blood Products Co., Ltd.'s profit margin?
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) keeps 18.29% of revenue as net profit after every cost, including tax and interest.